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Abstract  Porous three-dimensional hydroxyapatite scaffolds were synthesised from aragonitic cuttlefish bones via a 
microwave based technique. Due to its close similarity to the mineral phase found in the natural human bone matrix, 
synthetically produced hydroxyapatite is considered a viable apatite substitute for natural bone in a number of biomedical 
applications. The X-ray diffract ion data confirms the conversion of crystalline formations of calcium carbonate, the main 
component of the cuttlefish, to hydroxyapatite. The synthesis process is straightforward, efficient and creates a highly 
porous 3 dimensional microstructure that has the potential to be used in a wide range of hard tissue engineering 
applications such as bone repair, filling material and bone augmentation. 
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1. Introduction 
The human skeletal system is composed of a hard tissue 
called bone and more flexib le cartilaginous materials which 
provide the structural support and movement capability of 
the body[1]. In the event of an accident, where the bone is 
fractured or damaged due to diseases, bone substitutes are 
needed to repair the fracture or replacement the infected 
bone tissue[2]. The demand for natural bone and bone 
substitutes is high. In Australia  alone, the Australian 
Orthopaedic Association’s National Joint Replacement 
Registry recorded more than 75,000 hip and knee 
replacements being carried out annually[3]. Th is health 
issue is not unique to Australia  and has been identified by 
World Health Organization as one of the most serious 
health problems facing the world today[4]. 
In spite of being the most preferred  option, with its 
excellen t  b iocompat ib ility  and  osteogen ic capacity , 
autografts  have p rob lems  associated  with  donor s ite 
morb idity and limited supply[5, 6]. Given an adequate 
blood supply and no infection, autographs are successful 
donor t issues due to their ident ical nature. However, 
following the bone replacement procedure, patients receive 
immunosuppressive therapy which involves taking drugs 
designed to suppress the immune system. During the  
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therapy, many of these drugs used tend to kill rapid ly 
dividing cells and cause serious side effects. Therefore, to 
be a successful autograft procedure, right balance of 
immunosuppressive drugs and antibiotics to keep infection 
under control are needed to prevent implant site and donor 
morb idity. The autograft bone is usually harvested from the 
patient’s iliac crest in the form of cancellous bone. This 
means that the patient has only a limited number of 
potential harvest sites capable of supplying a suitable 
autograft. It is due to this limited supply that has led to the 
search for alternative sources of bone materials such as 
xenogenic and allogenic bone grafts. However, both of 
these replacement bone sources do solicit a significant 
detrimental response from the immune system. In spite of 
this allogenic bone grafts are routinely used due to the high 
clin ical demand[7, 8]. Nevertheless, concerns regarding the 
immune response and the possibility o f pathogen infection 
from bone sources have resulted in the search for alternative 
synthetic biocompatible materials have been investigated 
[9]. 
Inorganic materials such as calcium phosphate ceramics, 
porous coralline, and calcium sulphate’s have all been 
investigated in the past and demonstrated both good 
biocompatibility and bioactiv ity properties[10-12]. One 
particular material that has been extensively studied for a 
variety of bone repair and replacement procedures is 
hydroxyapatite (HAP), which is a member of the calcium 
phosphate family[13-15]. The stoichiometric chemical 
formula of HAP is[Ca10(OH)2(PO4)6] and is highly 
biocompatible due to its close chemical similarity to the 
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mineral component of natural bone[16]. There are four 
significant advantages of using HAP for bone t issue 
engineering: 1) it has been found to have good 
biocompatibility with surrounding body tissues; 2) it  is 
highly stable under a variety of physiological conditions 
and its biodegradability in situ is slow; 3) it p rovides good 
osteoconductivity, and 4) it has good osteoinductivity 
capabilit ies[17-22]. It is due to these favourable advantages 
that has resulted in HAP being used as the major component 
in bone cements and is routinely used to coat titanium based 
medical implants[23]. In the case of metallic implants, the 
HAP coating improves bone fixat ion, bone in-growth and 
increases the life span of the implant in the body. 
This paper reports the rapid chemical conversion of a 3-D 
porous CaCO3 micrometre scale structure found in 
cuttlefish bone to a HAP structure. A wet chemical 
technique, incorporating microwave heating was used 
during the conversion process. The advantage of using 
microwave heating in this process arises from the 
volumetric d istribution of energy throughout the material. 
This is fundamentally different to the conventional thermal 
conduction mechanism normally found in ovens and 
furnaces[24]. Unlike other hydrothermal based conversions 
of cuttlefish bone this microwave based conversion process 
is rapid in comparison[25, 26]. Thus, allowing a g reater 
throughput of material and improving the overall efficiency 
of the microwave based conversion process. Advanced 
characterisation techniques such as x-ray diffraction (XRD) 
and field emission scanning electron microscopy (FESEM) 
were used to investigate the effectiveness of the conversion 
process. XRD was used to verify the chemical conversion 
of CaCO3 to HAP, while FESEM microscopy was used to 
confirm the integrity of the 3-D micrometre scale structure 
after processing. The results of the XRD and FESEM 
analysis indicate that a 3-D micrometre scale HAP structure 
is formed at the end of the conversion process. 
2. Materials and Methods 
2.1. Materials 
All analytical grade reagents used in this work were 
supplied by Chem-Supply (Australia) and the cuttlefish 
bone samples were collected from a local beach. The main 
reactants used to synthesis the nanometre sized HAP 
powder used for comparative analysis consisted of calcium 
nitrate tetrahydrate[Ca(NO3)2.4H2O] and potassium 
di-hydrogen phosphate[KH2PO4]. During  the synthesis 
process the solution pH was maintained by the addition of 
ammonium hydroxide[NH4OH]. All aqueous solutions used 
throughout this study were made using Milli-Q® water (18.3 
MΩ  cm-1) produced by an ultrapure water system 
(Barnstead Ultrapure Water System D11931; Thermo 
Scientific, Dubuque, IA). 
2.2. Preparation of HAP Powder Used for Comparison 
Purposes 
The synthesis of the HAP powder begins by adjusting the 
pH of a 40 mL solution of 0.32M calcium n itrate 
tetrahydrate to a value of 9.0 by  adding and mixing 
approximately 2.5 mL of ammonium hydroxide. The 
solution was then exposed to ultrasound irradiat ion for 1 h 
using an UP50H Ultrasound Processor[50 W, 30 kHz, MS7 
Sonotrode (7mm d iameter, 80 mm length)] supplied by 
Hielscher Ult rasound Technology. During the second hour 
of ultrasonic irrad iation a 60 mL solution of 0.19 M 
potassium d i-hydrogen phosphate was slowly added 
drop-wise into the reactive mixture. Throughout the second 
hour the calcium:phosphate[Ca:P] rat io was maintained at 
1.67 and the solution pH maintained at 9.0. At the end of 
the second hour, the solution was filtered using 
centrifugation (15,000g) for 20 minutes at room 
temperature. The resultant white precipitate was then 
transferred to a fused silica crucible ready for thermal 
treatment. The thermal treatment consisted of p lacing the 
crucible into an LG® (Australia) household microwave 
rated at 1100 W  (2450 MHz) for 40 minutes. After cooling, 
the resulting white agglomerated mass was ground to form 
a fine powder and then characterised using XRD. A 
schematic presentation of the procedure is presented in 
Figure 1. 
 
Figure 1.  Schematic of the synthesis procedure used to produce nanometre scale HAP powders used for comparative analysis 
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Figure 2.  Schematic of cuttlefish conversion process to produce a 3-D HAP micrometre scale scaffold structure 
2.3. Microwave Based Conversion of Cuttlefish Samples 
The conversion process begins with a raw cuttlefish bone 
being washed and scrubbed to removal all traces of organic 
matter. In the next  stage, the cuttlefish bone was soaked in a 
series of Milli-Q® water solutions to progressively remove 
any sea salt (NaCl) content. After the salt had been removed, 
the cuttlefish bone was given a final wash in Milli-Q® water 
before being allowed to air dry. The dried cuttlefish bone 
was then cut up into 1 cm2 portions, with the thickness of 
the portions being 1 cm for samples being used for 
conversion. Each sample then underwent a pre-treatment 
procedure that consisted of two steps. In the first step each 
sample was placed into a 30% solution of ammonia 
(Chem-Supply, Australia) and permitted to soak fo r 30 
minutes. Following the initial soaking, a 0.19 M solution of 
K2H3PO4 was added to the solution. Then the solution 
containing the cuttlefish bone was then placed into a 
microwave bomb (45 ml, 4782 Parr Instrument Company) 
and sealed. The bomb was then placed into an LG® 
(Australia) household microwave oven rated at 1100 W 
(2450 MHz). The microwave was set to full power and the 
thermal t reatment was carried out over 10 minutes. The 
conversion procedure is presented schematically in Figure 2 
and images of the sample during processing are shown in 
Figure 3. After p rocessing samples were examined using 
XRD and FESEM. 
2.4. Characterisation of Materials 
Analysis of the XRD spectra was used to identify the 
HAP peaks in synthesised powders and examine the 
cuttlefish sample before and after conversion. The HAP 
powder pattern and the converted cuttlefish pattern were 
then compared and peak identification was carried out. 
XRD spectra were recorded at room temperature, using a 
Siemens D500 series diffractometer[Cu Kα  = 1.5406 Å 
radiation source] operating at 40 kV and 30 mA. 
The diffraction patterns were collected over a 2θ range 
from 20° to 60° with an incremental step size of 0.04° using 
flat p lane geometry. The acquisition time was set at 2 
seconds for each scan. The morphological features of the 
converted cuttlefish samples were investigated using 
FESEM. All micrographs were taken using a high 
resolution FESEM[Zeiss 1555 VP-FESEM] at 3 kV with a 
30 µm aperture operating under a pressure of 1×10-10 Torr. 
In addition, the FESEM micrographs were also used to 
estimate the size of major structure features seen in the 
images. 
 
Figure 3.  Conversion process: (a) ammonia soaking of cuttlefish bone 
for 30 min; (b) addition of K2H3PO4 and placing solution into microwave 
bomb; (c) sealed bomb placed in Microwave oven for thermal treatment, 
and (d) cuttlefish bone converted to 3-D HAP micrometre scale scaffold 
structure 
3. Results and Discussions 
The XRD technique was used to identify and confirm the 
presence of crystalline HAP both in the synthesised powder 
used for comparative purposes and the converted cuttlefish 
samples. A typical XRD pattern of the synthesised ultra fine 
HAP powder is presented in Figure 4 and reveals the main 
(h k l) indices associated with HAP: (002), (211), (300), 
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(202), (130), (002), (222) and (213). The (002) reflection 
peak from the XRD pattern was used to calculate the 
crystallite size of the powder using the Debye-Scherrer 
equation (Insert Figure 4)[27, 28]. The crystallite size was 
estimated to have a mean value of 30 ± 5 nm. The HAP 
XRD spectra as then used to in a comparative study 
between the pre-treated cuttlefish and the converted 
cuttlefish. 
The cuttlefish sample spectrum (b) prior to treatment is 
presented in Figure 5 and reveals an XRD pattern with 
numerous peaks indicat ing the presence of a CaCO3 based 
structure. The post-treatment sample spectrum (c) reveals a 
pattern that is similar to the synthesized HAP sample 
spectra (a). The peaks in the left hand side of the pattern are 
dominant, can be easily seen and clearly indicate the 
presence of the (002), (211), (300) and (202) indices. In the 
right hand side of the spectrum the peaks are not as 
prominent, but can still be identified as the (130), (222), 
(213) and (004) indices. In the pre-treated sample the 
CaCO3 peaks on the right hand side of the spectrum were 
quite dominant. This is not the case after treatment where 
the peaks are significantly s maller. The results of the XRD 
study have clearly shown that the cuttlefish sample has been 
effectively  converted into HAP during the treatment 
process.  
 
Figure 4.  A typical experimental XRD spectrum of the synthesized HAP powder used for comparative purposes 
 
Figure 5.  Comparisons between the XRD spectra of synthesised HAP powder (a), pre-treated cuttlefish bone sample (b) and converted cuttlefish bone 
sample (c) 
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After the conversion process the sample was still soft and 
retains the 3-D micrometre scale structure seen in the 
original cuttlefish sample as seen in Figure 6. Inspection of 
Figure 6 reveals that there is some surface damage to the 
3-D structure resulting from the in itial removal of o rganic 
material. Among the parallel longitudinal wall structures, 
many of the smaller walls between the individual chambers 
have been damaged to varying degrees. However, the 
overall structure is still intact and the damage is minimal 
since it is not widespread across the surface of the sample 
(typically, around 20% max). Despite the minor surface 
damage to the sample, cells would still be able to enter and 
move freely within the structure due to their s mall size 
(generally in between 10 to 20 µm)[29]. 
 
Figure 6.  A typical FESEM micrograph of the converted cuttlefish bone 
sample showing structural damage caused during the removal of organic 
material in the pre-treatment stage of processing 
The advantage of the microwave based technique is that 
the conversion times are relatively short compared to other 
non-microwave based techniques[25]. In addition, the 
microwave based technique has only one heating cycle and 
does not need a secondary independent heating cycle at 
higher temperatures for extended periods to achieve 
calcinations[26]. Th is makes the microwave based 
technique more efficient and as a result cost effective in 
converting the cuttlefish bone to HAP compared to 
conventional hydrothermal processes that have much longer 
processing times. However, further work is needed to 
develop a less aggressive cleaning technique to reduce 
surface damage during the removal of organic material. 
Also, future cell studies are planned to thoroughly 
investigate the biocompatibility of novel 3-D HAP structure. 
The converted sample is firm and can easily be formed into 
a variety of shapes and profiles, which makes it suitable for 
a number of potential tissue engineering applications[30, 
31]. However, the material would  be unsuitable for large 
load bearing applications in a number of hard t issue 
engineering procedures. 
4. Conclusions 
HAP is an important biocompatible material used in 
biomedical and tissue engineering applications. The results 
of this study have shown that the conversion of CaCO3 
based cuttlefish bones to a 3-D HAP micrometre scale 
structure is simple and straightforward. The resultant HAP 
material resembles the mineral phase found in natural bone 
tissue, with the advantage of being modelled into a definite 
shape for a specific application. This highly  porous HAP 
structure has the potential to be used as a cell scaffold  for 
tissue engineering applications.  
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